Polymorphisms of the promoter and exon 3 of the receptor for advanced glycation end products (RAGE) in Euro- and Afro-Brazilians

International Journal of Immunogenetics

Volumn 39, Issue 2, 2012, Pages 155-160

  Torres, M C ^a   Beltrame, M H ^a   Santos, I C R ^a   Picheth, G ^a   Petzl Erler, M L ^a   Pedrosa, F O ^a   Steffens, M B R ^a   de Souza, E M ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALANINE; CYSTEINE; GLYCINE; SERINE; THREONINE;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BRAZIL; CONTROLLED STUDY; ETHNIC GROUP; EXON; FEMALE; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEREDITY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; BASE SEQUENCE; BRAZIL; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; GENE FREQUENCY; GENETICS, POPULATION; GENOTYPING TECHNIQUES; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RECEPTORS, IMMUNOLOGIC; SEQUENCE DELETION;

EID: 84858080103     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2011.01073.x     Document Type: Article

References (47)

1. Bierhaus, A., Haslbeck, K.M., Humpert, P.M., Liliensiek, B., Dehmer, T., Morcos, M. et al. (2004) Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. The Journal of Clinical Investigation, 114, 1741.
2. Braun-Prado, K., Vieira Mion, A.L., Farah Pereira, N., Culpi, L. & Petl-Erler, M.L. (2000) HLA class I polymorphism, as characterized by PCR-SSOP, in a Brazilian exogamic population. Tissue Antigens, 56, 417.
3. Chavakis, T., Bierhaus, A. & Nawroth, P.P. (2004) RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes and Infection, 6, 1219.
4. Ding, Q. & Keller, J.N. (2005) Evaluation of RAGE isoforms, ligands, and signaling in the brain. Biochimica et Biophysica Acta, 1746, 18.
5. Excoffier, L., Laval, G. & Schneider, S. (2005). Arlequin ver. 3.0: An integrated software package for population genetics data analysis. Evolutionary Bioinfomatics, 1, 47.
6. Falcone, C., Campo, I., Emanuele, E., Buzzi, M.P., Zorzetto, M., Sbarsi, I. & Cuccia, M. (2004) Relationship between the -374T/A RAGE gene polymorphism and angiographic coronary artery disease. International Journal of Molecular Medicine, 14, 1061-1064.
7. Goulart, A.C., Germer, S., Rexrode, K.M., Martin, M. & Zee, R.Y. (2008) Polymorphisms in advanced glycosylation end product-specific receptor (AGER) gene, insulin resistance, and type 2 Diabetes mellitus. Clinica Chimica Acta, 398, 95.
8. Hofmann, M.A., Drury, S., Hudson, B.I., Gleason, M.R., Qu, W., Lu, Y. et al. (2002) RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes and Immunity, 3, 117.
9. Hofmann, M.A., Yang, Q., Harja, E., Kedia, P., Gregersen, P.K., Cupples, L.A., Schmidt, A.M. & Hudson, B.I. (2005) The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study. Atherosclerosis, 182, 301.
10. Hudson, B.I., Stickland, M.H. & Grant, P.J. (1998) Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene. Diabetes, 47, 1155.
11. Hudson, B.I., Stickland, M.H., Grant, P.J. & Futers, T.S. (2001a) Characterization of allelic and nucleotide variation between the RAGE gene on chromosome 6 and a homologous pseudogene sequence to its 5′ regulatory region on chromosome 3 - Implications for polymorphic studies in diabetes. Diabetes, 50, 2646.
12. Hudson, B.I., Stickland, M.H., Futers, T.S. & Grant, P.J. (2001b) Effects of novel polymorphisms in the AGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes, 50, 1505.
13. Hudson, B.I., Stickland, M.H., Futers, T.S. & Grant, P.J. (2001c) Study of the -429T>C and -374T>A receptor for advanced glycation end products promoter polymorphisms in diabetic and nondiabetic subjects with macrovascular disease. Diabetes Care, 24, 2004.
14. Hudson, B.I., Holfmann, A.M., Bucciarelli, L., Wendt, T. et al. (2002) Glycation and diabetes: the RAGE connection. Diabetes, 83, 1515.
15. Jixiong, X., Bilin, X., Minggong, Y. & Shuqin, L. (2003) -429T>C and -374T>A polymorphisms of RAGE gene promoter are not associated with diabetic retinopathy in Chinese patients with type 2 diabetes. Diabetes Care, 26, 2696.
16. Kalea, A.Z., Schmidt, A.M. & Hudson, B.I. (2009) RAGE: a novel biological and genetic marker for vascular disease. Clinical Science (Lond), 116, 621.
17. Kalea, A.Z., Schmidt, A.M. & Hudson, B.I. (2011) Alternative splicing of RAGE: roles in biology and disease. Frontiers in Bioscience, 17, 2756.
18. Kalousová, M., Jáchymová, M., Germanová, A., Kubena, A.A., Tesar, V. & Zima, T. (2010) Genetic predisposition to advanced glycation end products toxicity is related to prognosis of chronic hemodialysis patients. Kidney & Blood Pressure Research, 33, 30.
19. Kanková, K., Vasku, A., Hajek, D., Zahejský, J. & Vasku, V. (1999) Association of G82S polymorphism in the RAGE gene with skin complications in type 2 diabetes. Diabetes Care, 22, 1745.
20. Kanková, K., Marova, I., Zahejsky, J., Muzík, J., Stejskalová, A., Znokil, V. & Vácha, J. (2001) Polymorphisms 1704G>T and 2184A>G in the RAGE gene are associated with antioxidant status. Metabolism, 50, 1152.
21. Kanková, K., Stejskalová, A., Hertlová, M. & Znojil, V. (2005) Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus. Nephrology Dialysis Transplantation, 20, 1093.
22. Kirbis, J., Milutinović, A., Steblovnik, K., Teran, N., Terzic, R. & Zorc, M. (2004) The -429T/C and -374T/A gene polymorphisms of the receptor of advanced glycation end products gene (RAGE) are not risk factors for coronary artery disease in Slovene population with type 2 diabetes. Collegium Antropologicum, 28, 611.
23. Kumaramanickavel, G., Ramprasad, V.L., Spripriya, S., Upadyay, N.K. et al. (2002) Association of Gly82Ser polymorphism in the RAGE gene with diabetic retinopathy in type II diabetic Asian Indian patients. Journal of Diabetes and its Complications, 16, 391.
24. Lahiri, D.K. & Nurnberger, J.I. (1991) A rapid non-enzymatic method for the preparation of DNA from blood for FRLP studies. Nucleic Acids Research, 19, 5444.
25. Laki, J., Kiszel, P., Vatay, A., Blaskó, B., Kovács, M., Körner, A. et al. (2007) The HLA 8.1 ancestral haplotype is strongly linked to the C allele of -429T>C promoter polymorphism of receptor of the advanced glycation endproduct (RAGE) gene. Haplotype-independent association of the -429C allele with high hemoglobinA1C levels in diabetic patients. Molecular Immunology, 44, 648.
26. Li, K., Zhao, B., Daí, D., Yao, S., Liang, W., Yao, L. & Yang, Z. (2011) A functional p.82G>S polymorphism in the RAGE gene is associated with multiple sclerosis in the Chinese population. Multiple Sclerosis, 17, 914.
27. Liu, L. & Xianc, K. (1999) RAGE Gly82Ser polymorphism diabetic microangiopathy. Diabetes Care, 22, 616.
28. Miller, M.P. (1997) RxC: A Program for the Analysis of Contingency Tables via the Metropolis Algorithm Computer. Department of Biological Sciences, Northern Arizona University, Flagstaff.
29. Naka, C.L., Picheth, G., Alcântara, V.M., Réa, R.R., Chautard-Freire-Maia, E.A., Pedrosa, F.O. et al. (2006) The Gly82Ser polymorphism of the receptor of advanced glycation end products (RAGE) gene is not associated with type 1 or type 2 diabetes in a Brazilian population. Diabetes Care, 29, 712.
30. NCBI (2009). Single nucleotide polymorphism (NCBI). (search rs1800624 and rs1800625). [Accessed on 10 December 2009].
31. Pettersson-Fernholm, K., Forsblom, C., Hudson, B.I., Peroloa, M., Grant, P.J., Groop, P.H. et al. (2003) The functional -374T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. Diabetes, 52, 891.
32. Picheth, G., Costantini, C.O., Pedrosa, F.O., Martinez, T.L.R. & Souza, E.M. (2007a) The -374A allele of the receptor for advanced glycation end products (RAGE) gene promoter is a protective factor against cardiovascular lesions in type 2 diabetes mellitus patients. Clinical Chemistry Laboratory Medicine, 45, 1268.
33. Picheth, G., Heidemann, M., Pedrosa, F.O., Chautard-Freire-Maia, E.A., Constantini, C.O., da Rocha Martinez, T.L. et al. (2007b) The -429 T>C polymorphism of the receptor for advanced glycation end products (RAGE) is associated with type 1 diabetes in a Brazilian population. Clinica Chimica Acta, 383, 163.
34. Probst, C.M., Bompeixe, E.P., Pereira, N.F., Dalalio, M.M.O., Visentainer, J.E., Tsuneto, L.T. & Petzl-Erler, M.L. (2000) HLA polymorphism and evaluation of European, African, and Amerindian contribution to the white and mulato populations from Parana, Brazil. Human Biology, 72, 597.
35. Pulkkinen, A., Viitanen, L., Kareinen, A., Lehto, A. & Laakso, M. (2000) Gly82Ser polymorphism of the receptor of advanced glycation end product gene is not associated with coronary heart disease in Finnish nondiabetic subjects or in patients with type 2 diabetes. Diabetes Care, 23, 864.
36. Ramasamy, R., Yan, S.F. & Schmidt, A.M. (2009) RAGE: therapeutic target and biomarker of the inflammatory response-the evidence mounts. Journal of Leukocyte Biology, 86, 505.
37. Santos, K.G., Canani, L.H., Gross, J.L., Tschiedel, B., Pires Souto, K.E. & Roisenberg, I. (2005) The -374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes. Molecular Genetics and Metabolism, 85, 149.
38. Santos, I.C.R., Daga, D.R., Frigeri, H.R., Réa, R.R., Almeida, A.C.R., Souza, E.M., Pedrosa, F.O., Fadel-Picheth, C.M.T. & Picheth, G. (2010) The functional polymorphisms -429T>C and -374T>A of the RAGE gene promoter are not associated with gestational diabetes in Euro-Brazilians. Genetics and Molecular Research, 9, 1130.
39. Schenk, S., Schraml, P., Bendik, I. & Ludwig, C.U. (2001) A novel polymorphism in the promoter of the RAGE gene is associated with non-small cell lung cancer. Lung Cancer, 32, 7.
40. Schmidt, A.M. & Stern, D.M. (2000) RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes. Trends in Endocrinology and Metabolism, 11, 368.
41. Schmidt, A.M., Yan, S.D., Yan, S.F. & Stern, D.M. (2001) The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. The Journal of Clinical Investigation, 108, 949.
42. Selkoe, D.J. (1994) Alzheimer's disease: a central role for amyloid. Journal of Neuropathology and Experimental Neurology, 53, 438.
43. Steenvoorden, M.M., Van Der Helm-Van Mil, A.H., Stoeken, G., Bank, R.A., Devries, R.R., Huizinga, T.W., Degroot, J. & Toes, R.E. (2006) The RAGE G82S polymorphism is not associated with rheumatoid arthritis independently of HLA-DRB1*0401. Rheumatology, 45, 488.
44. Stern, D., Yan, S.D., Yan, S.F. & Schmidt, A.M. (2002) Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Advanced Drug Delivery Reviews, 54, 1615.
45. Sugaya, K., Fukagawa, T., Matsumoto, K.I., Mita, K., Takahashi, E., Ando, A., Inoko, H. & Ikemura, T. (1994) Three genes in the human MHC class III region near junction with the class II: gene for receptor for advanced glycosylation end products, PBX2 homebox gene and a Notch homolog, human counterpart of mouse mammary tumor gene int-3. Genomics, 23, 408.
46. Vaskú, V., Kanková, K., Vaskú, A., Muzik, J., Izakovicová Hollá, L., Semrádová, V. & Vácha, J. (2002) Gene polymorphisms (G82S, 1704G/T, 2184 A/G and 2245G/A) of the receptor of advanced glycation end products (RAGE) in plaque psoriasis. Archives of Dermatological Research, 294, 127.
47. Yoshioka, K., Yoshida, T., Takakura, Y., Umekawa, T., Kogure, A., Toda, H. & Yoshikawa, T. (2005) Association study of G1704T e G82S polymorphisms of RAGE gene for microalbuminuria in Japanese type 2 diabetic patients. Metabolism: Clinical and Experimental, 54, 488.